-
P&L Statement | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Revenue | 111 | 214 | 392 | 547 |
Cost of Material Consumed | 61 | 147 | 255 | 341 |
Gross Margins | 45.05 | 31.31 | 34.95 | 37.66 |
Change in Inventory | 1 | -6 | -7 | 6 |
Employee Benefit Expenses | 21 | 28 | 39 | 47 |
Other Expenses | 15 | 24 | 51 | 66 |
EBITDA | 13 | 21 | 54 | 87 |
OPM | 11.71 | 9.81 | 13.78 | 15.9 |
Other Income | 1 | 1 | 1 | 1 |
Finance Cost | 6 | 5 | 8 | 10 |
D&A | 2 | 2 | 3 | 5 |
EBIT | 11 | 19 | 51 | 82 |
EBIT Margins | 9.91 | 8.88 | 13.01 | 14.99 |
PBT | 5 | 15 | 45 | 74 |
PBT Margins | 4.5 | 7.01 | 11.48 | 13.53 |
Tax (2021) | 0 | 0 | 12 | 21 |
PAT | 5 | 15 | 33 | 53 |
NPM | 4.5 | 7.01 | 8.42 | 9.69 |
EPS | 2.23 | 6.69 | 14.71 | 23.56 |
Financial Ratios | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Operating Profit Margin | 11.71 | 9.81 | 13.78 | 15.9 |
Net Profit Margin | 4.5 | 7.01 | 8.42 | 9.69 |
Earning Per Share (Diluted) | 2.23 | 6.69 | 14.71 | 23.56 |
Assets | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Fixed Assets | 24 | 26 | 54 | 76 |
CWIP | 0 | 1 | 13 | 13 |
Investments | 0 | 0 | 0.26 | 0.4 |
Trade Receivables | 30 | 43 | 60 | 87 |
Inventory | 48 | 66 | 78 | 76 |
Other Assets | 22 | 48 | 58.74 | 49.6 |
Total Assets | 124 | 184 | 264 | 302 |
Liabilities | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Share Capital | 22.43 | 22.43 | 22.43 | 22.5 |
FV | 10 | 10 | 10 | 10 |
Reserves | 1 | 16 | 49 | 101 |
Borrowings | 21 | 19 | 58 | 75 |
Trade Payables | 37 | 32 | 39 | 56 |
Other Liabilities | 42.57 | 94.57 | 95.57 | 47.5 |
Total Liabilities | 124 | 184 | 264 | 302 |
Cash-Flow Statement | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
PBT | 5 | 15 | 45 | 74 |
OPBWC | 9 | 17 | 48 | 91 |
Change in Receivables | -7 | -12 | -17 | -30 |
Change in Inventories | -7 | -18 | -12 | 2 |
Change in Payables | -9 | -5 | 7 | 15 |
Other Changes | 24 | 37 | -12 | -52 |
Working Capital Change | 1 | 2 | -34 | -65 |
Cash Generated From Operations | 10 | 19 | 14 | 26 |
Tax | 0 | 0 | 0 | -7 |
Cash Flow From Operations | 10 | 19 | 14 | 19 |
Purchase of PPE | -3 | -5 | -43 | -30 |
Sale of PPE | 0 | 0 | 0 | 0 |
Cash Flow From Investment | -5 | -4 | -42 | -28 |
Borrowing | 0.24 | 6.5 | -3 | 17.5 |
Divided | 0 | 0 | 0 | 0 |
Equity | 0.76 | 0 | 0 | 0 |
Others From Financing | -6 | -15.5 | 34 | -9.5 |
Cash Flow from Financing | -5 | -9 | 31 | 8 |
Net Cash Generated | 0 | 6 | 3 | -1 |
Cash at the Start | 0.24 | 5 | 11 | 1.4 |
Cash at the End | 0.24 | 11 | 14 | 0.4 |
Shareholding Pattern | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Mr. Vivek Verma | 53.99% | 53.99% | 53.99% | 53.99% |
Mr. Prateek Verma | 26.31% | 26.31% | 26.31% | 26.31% |
Klondike Investments Ltd | 12.50% | 12.50% | 12.50% | 12.50% |
Others | 7.20% | 7.20% | 7.20% | 7.20% |